Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting
Tetsuya Matoba(Kyushu University), Shun Nakamura, Satoshi Yasuda(Tohoku University), Hisao Ogawa(Kumamoto University Hospital), Eiichi Tamiya(Osaka Gakuin University), Masaharu Akao(Kyoto Medical Center), Kunihiko Matsui(Kumamoto University), Tetsuya Sumiyoshi(Kyushu University), Kazuo Kimura(Yokohama City University Medical Center), Tsutomu Yamazaki(University of Tokyo Hospital), Masato Nakamura(Toho University), Teruo Noguchi(National Cerebral and Cardiovascular Center), Syuji Suetake, Junya Ako(E Ink (South Korea)), Yasushi Okada(National Kyushu Medical Center), Akira Nakamura, Hiroyuki Daida(Juntendo University Hospital), Takashi Yamamoto(Koga Hospital), Koichi Kaikita(Kumamoto University), Kazumi Kimura(Yokohama City University Medical Center), Yukihiro Koretsune(Osaka National Hospital), Katsumi Miyauchi(Tokyo Metropolitan Geriatric Hospital), Takafumi Hiro(Institute for Atherosclerosis Research), Nobuhisa Hagiwara(Tokyo Women's Medical University), Atsushi Hirayama(Nihon University), Yoichiro Hashimoto(Saiseikai Kumamoto Hospital), Teruyuki Hirano(The Graduate University for Advanced Studies, SOKENDAI)
Cited by 22
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821